Journal article icon

Journal article

Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort

Abstract:

Circulating osteoprotegerin (OPG), a member of the receptor activator of nuclear factor kappa-B (RANK) axis, may influence breast cancer risk via its role as the decoy receptor for both the RANK ligand (RANKL) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Circulating OPG and breast cancer risk has been examined in only one prior study.A case-control study was nested in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. A total of 2008 incide...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1186/s12916-017-0786-8

Authors


Fortner, RT More by this author
Johnson, T More by this author
Tjønneland, A More by this author
Expand authors...
Publisher:
BioMed Central Publisher's website
Journal:
BMC Medicine Journal website
Volume:
15
Issue:
1
Pages:
Article: 26
Publication date:
2017-02-08
DOI:
ISSN:
1741-7015
Pubs id:
pubs:680519
URN:
uri:9800c77c-44ef-418a-a7ab-6453f532b6aa
UUID:
uuid:9800c77c-44ef-418a-a7ab-6453f532b6aa
Local pid:
pubs:680519

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP